24-Apr-2024
Globe Newswire (Wed, 24-Apr 7:00 AM ET)
Business Wire (Tue, 23-Apr 9:30 AM ET)
Goldman’s buybacks basket: Buyback growth will be 13% in 2024
Seeking Alpha News (Mon, 22-Apr 1:23 PM ET)
Fortune Names HCA Healthcare One of the World's Most Admired Companies
Business Wire (Mon, 22-Apr 8:30 AM ET)
Business Wire (Fri, 19-Apr 9:30 AM ET)
HCA Healthcare, Inc. to Present at May Healthcare Conferences
Business Wire (Wed, 3-Apr 8:30 AM ET)
HCA Healthcare Releases 2024 Annual Impact Report
Business Wire (Thu, 28-Mar 8:30 AM ET)
HCA Healthcare, Inc. 1st Quarter 2024 Earnings Conference Call
Business Wire (Mon, 25-Mar 8:30 AM ET)
HCA Healthcare Names Dr. Monique Butler as President of Graduate Medical Education
Business Wire (Tue, 12-Mar 8:30 AM ET)
HCA Healthcare Named as One of the 2024 World's Most Ethical Companies by Ethisphere
Business Wire (Mon, 4-Mar 8:30 AM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of April 24, 2024, HCA stock price declined to $319.02 with 788,677 million shares trading.
HCA has a beta of 1.03, meaning it tends to be more sensitive to market movements. HCA has a correlation of 0.28 to the broad based SPY ETF.
HCA has a market cap of $84.38 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $17 billion in Revenue and $5.90 earnings per share. This beat revenue expectation by $793 million and exceeded earnings estimates by $.86.
In the last 3 years, HCA stock traded as high as $335.83 and as low as $164.47.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
HCA has underperformed the market in the last year with a price return of +14.3% while the SPY ETF gained +24.2%. However, in the short term, HCA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.2% vs +4.6% return in SPY. But in the last 2 weeks, HCA shares have been beat by the market, returning -3.0% compared to an SPY return of -2.7%.
HCA support price is $314.27 and resistance is $324.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA stock will trade within this expected range on the day.